Latest Articles

Publication Date
March 1, 2026 Special Days and Important Dates: Endometriosis Awareness Day, Zero Discrimination Day – Full List of National and International Events - Bombay Times

March 1, 2026 Special Days and Important Dates: Endometriosis Awareness Day, Zero Discrimination Day – Full List of National and International Events Bombay Times

Published: Feb. 28, 2026, 11:30 a.m.
We have endometriosis: Here’s what we wish more people knew about the condition - The Portugal News

We have endometriosis: Here’s what we wish more people knew about the condition The Portugal News

Published: Feb. 28, 2026, 11:10 a.m.
DRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs.

Multi-omics data are instrumental in obtaining a comprehensive picture of complex biological systems. This is particularly useful for women's health conditions such as endometriosis, which has been historically understudied despite …

Published: Feb. 28, 2026, midnight
Integrating ultrasound findings and extreme CA-125 elevation in the diagnosis of spontaneous endometrioma rupture: a case report.

Introduction: Spontaneous rupture of an endometrioma may result in life-threatening condition. Detection and prompt treatment are necessary. Presentation of Case: A 27-year-old woman presented to labor and delivery unit with …

Published: Feb. 28, 2026, midnight
Pathologic, Laboratory, and Surgical Findings of Topical Statin Gels (Simvastatin, Atorvastatin, and Rosuvastatin) in a Rat Model of Peritoneal Endometriosis.

Endometriosis is a chronic inflammatory disease with frequent recurrence. Statins, due to their anti-inflammatory and antioxidant properties, may help control disease progression, but comparative data on local administration are limited. …

Published: Feb. 28, 2026, midnight
ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon - TipRanks

ACR-368 in Serous Endometrial Cancer: Strong Phase 2b Efficacy, Manageable Safety, and a Clear Accelerated Approval Path Support Buy Rating on Acrivon TipRanks

Published: Feb. 27, 2026, 7:47 p.m.
'Years being dismissed': Endometriosis patient campaigns for Jess's rule in Wales - ITVX

'Years being dismissed': Endometriosis patient campaigns for Jess's rule in Wales ITVX

Published: Feb. 27, 2026, 6:51 p.m.
How Endometriosis Patients Can Change The World: Cat Bohannon On Healt - Endometriosis Foundation of America

How Endometriosis Patients Can Change The World: Cat Bohannon On Healt Endometriosis Foundation of America

Published: Feb. 27, 2026, 4:54 p.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - MarketBeat

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer MarketBeat

Published: Feb. 27, 2026, 4:50 p.m.
Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer - Yahoo Finance

Acrivon Therapeutics Conference Highlights ACR-368 Phase 2B Data, 52% ORR in Serous Endometrial Cancer Yahoo Finance

Published: Feb. 27, 2026, 4:47 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!